THE Drug Utilisation Sub-Committee of the Pharmaceutical Benefits Advisory Committee has published the outcomes from its latest meeting in late Sep, reviewing febuxostat, hepatitis C medicines, ruxolitinib and bevacizumab - see pbs.gov.au.
THE Pharmacy Guild of Australia has raised concerns over Echo Therapeutics’ decision to limit distribution of Pegasys (Peginteferon Alfa-2A) injections exclusively through Echo’s home delivery partner, JustMeds, citing the approach as a disruption to patient choice and National Medicines Policy principles.
DR JARED Miles, a Yuwi man and lecturer in the University of Queensland’s (UQ) School of Pharmacy, is addressing the significant underrepresentation of Indigenous people in Australia’s pharmacy workforce.
THE 2024 Liptember campaign, in partnership with Chemist Warehouse Group, has raised $2.1 million for women’s mental health, marking 15 years of the annual initiative.